两例胚胎嵌合体经PGT-A识别并在妊娠期间持续为真性胎儿嵌合体的临床病例报告
两例经PGT-A判定为嵌合体的胚胎移植后,嵌合体在妊娠期持续存在。例1为1号染色体低水平片段性嵌合缺失,羊膜腔穿刺及流产组织脑组织均确认,因与1p36缺失综合征相关的染色体异常而终止妊娠。例2为21三体低水平嵌合,绒毛膜绒毛取样及羊膜腔穿刺确认,超声发现胎盘和胎儿严重异常后终止妊娠。
要点
- 例1胚胎为1号染色体低水平片段性嵌合缺失,羊膜腔穿刺及流产组织脑组织均确认嵌合持续存在。
- 例1因与1p36缺失综合征相关的染色体异常(如严重智力障碍)而终止妊娠。
- 例2为21三体低水平嵌合,绒毛膜绒毛取样及羊膜腔穿刺确认,超声发现胎盘和胎儿严重异常后终止妊娠。
核心结论
- 两例病例显示胚胎嵌合体可在妊娠期间持续为真性胎儿嵌合体,应在评估拟移植嵌合胚胎的风险-获益时予以考虑。
研究设计与样本
- 两例临床病例报告,报告经PGT-A判定为嵌合体并移植后妊娠的病例。
主要发现
- 例1为1号染色体低水平片段性嵌合缺失,羊膜腔穿刺及流产组织脑组织均确认,因与1p36缺失综合征相关的染色体异常(如严重智力障碍)而终止妊娠。
- 例2为21三体低水平嵌合,绒毛膜绒毛取样及羊膜腔穿刺确认,超声发现胎盘和胎儿严重异常后终止妊娠。
临床怎么用
- 作者认为,这两例病例应在评估拟移植嵌合胚胎的风险-获益时予以考虑。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The health risks associated with transferring embryos classified as mosaic by preimplantation genetic testing for aneuploidies (PGT-A) are currently unknown. Such embryos produce PGT-A results indicating the presence of both euploid and aneuploid cells and have historically been deselected from transfer and grouped with uniformly aneuploid embryos as 'abnormal'. In recent years, numerous groups have reported the intentional transfer of mosaic embryos in the absence of uniformly euploid embryos, largely observing births of seemingly healthy babies. However, it remains to be understood whether the embryonic mosaicism invariably becomes resolved during the ensuing pregnancy, or whether the placenta and/or fetal tissues retain aneuploid cells, and if so to what potential clinical effect. Here, we report two cases of mosaicism persisting from the embryonic stage to the established pregnancy. Case 1 involved an embryonic low-level segmental mosaic loss in Chromosome (Chr) 1, which was confirmed in amniocentesis as well as in brain tissue of the products of conception. This pregnancy was terminated due to the chromosomal pathologies associated with 1p36 deletion syndrome, such as severe intellectual disability. Case 2 involved a low-level mosaic Chr 21 trisomy, which was confirmed with chorionic villus sampling and amniocentesis. The ensuing pregnancy was terminated after ultrasound identification of severe abnormalities in the placenta and fetus. Together, these two cases should be taken into account for risk-benefit assessments of prospective mosaic embryo transfers.
引用
- Greco E, Yakovlev P, Kornilov N, et al. Two clinical case reports of embryonic mosaicism identified with PGT-A persisting during pregnancy as true fetal mosaicism. Hum Reprod. 2023. PMID: 36610460. doi:10.1093/humrep/deac263
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。